Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
IgG4-Related Disease
Do you generally request IgG4 staining on all of your salivary gland biopsies in seronegative patients presenting with dry mouth?
Related Questions
For suspected IgG4-RD, what imaging modality do you use in your practice for initial diagnostic evaluation?
In a patient with prior biopsy-proven IgG4-related pachymeningitis who develops recurrent neurologic symptoms years after discontinuing immunosuppression, how do you determine whether this represents relapse versus alternative etiologies?
How do you approach management of a patient with a retroperitoneal soft tissue mass and elevated IgG4 level when tissue biopsy is not feasible?
When evaluating a patient with IgG4-related disease, are there particular exposures or risk factors you routinely ask about during the history to help identify potential contributors?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
How would you approach a patient with history of cocaine use presenting with chronic sinusitis and acute vision loss from an extensive inflammatory changes in the sinus and orbit compressing the optic nerve with negative ANCA, inconclusive nasal biopsy and elevated serum IgG4?
Do you offer antibiotic therapy for patients with a chronic joint infection, with no plans for surgery, and with an open draining sinus tract?
What are your recommendations for perioperative management of DMARDs and biologics in patients undergoing bariatric surgery?
Would you consider upadacitinib for GCA in a patient with history of breast cancer now in remission?
What patient factors are most important when considering who needs a broader workup for osteoporosis prior to starting therapy?
